Table 5.
Pharmacological prophylaxis | women and men | women | men |
---|---|---|---|
tranexamic acid | 10 | 6 (10 %) | 4 (8 %) |
danazol | 26 | 13 (23 %) | 13 (27 % |
IRT | |||
pd C1 - INH | 9 | 7 (12 %) | 2 (4 %) |
Therapy of acute attacks | |||
Icatibant | 12 | 9 (16 %) | 3 (6 %) |
pd C1 – INH | 57 | 32 (56 %) | 25 (53 %) |
Percentages are related in women to the total amount of women, in men to the total amount of men